Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
L. M. Dorsch, Maike Schuldt, Cristobal G. dos Remedios, et al.
Cells (2019) Vol. 8, Iss. 7, pp. 741-741
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration
Edgar E. Nollet, Inez Duursma, Anastasiya Rozenbaum, et al.
European Heart Journal (2023) Vol. 44, Iss. 13, pp. 1170-1185
Open Access | Times Cited: 53
Microtubules Increase Diastolic Stiffness in Failing Human Cardiomyocytes and Myocardium
Matthew A. Caporizzo, Yingxian Chen, Ken Bedi, et al.
Circulation (2020) Vol. 141, Iss. 11, pp. 902-915
Open Access | Times Cited: 83
Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy
Adam Helms, Vi T. Tang, Thomas S. O’Leary, et al.
JCI Insight (2019) Vol. 5, Iss. 2
Open Access | Times Cited: 79
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy
Maike Schuldt, Jiayi Pei, Magdaléna Harakaľová, et al.
Circulation Heart Failure (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 77
Reductive Stress-Induced Mitochondrial Dysfunction and Cardiomyopathy
WEI-XING MA, Chunyan Li, Ran Tao, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 46
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
Rudolf A. de Boer, Stéphane Heymans, Johannes Backs, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 3, pp. 406-420
Open Access | Times Cited: 39
Burst-Like Transcription of Mutant and Wildtype MYH7-Alleles as Possible Origin of Cell-to-Cell Contractile Imbalance in Hypertrophic Cardiomyopathy
Judith Montag, Kathrin Kowalski, Mirza Makul, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 43
Depletion of Vasohibin 1 Speeds Contraction and Relaxation in Failing Human Cardiomyocytes
Yingxian Chen, Alexander K. Salomon, Matthew A. Caporizzo, et al.
Circulation Research (2020) Vol. 127, Iss. 2
Open Access | Times Cited: 35
Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations
J. Pei, Maike Schuldt, E. Nagyova, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 29
ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes
Antonia T.L. Zech, Maksymilian Prondzynski, Sonia R. Singh, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2745-2745
Open Access | Times Cited: 20
Alpha kinase 3 signaling at the M-band maintains sarcomere integrity and proteostasis in striated muscle
James W. McNamara, Benjamin L. Parker, Holly K. Voges, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 2, pp. 159-173
Open Access | Times Cited: 13
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy
Roua Hassoun, Heidi Budde, Saltanat Zhazykbayeva, et al.
International Journal of Cardiology (2021) Vol. 344, pp. 160-169
Open Access | Times Cited: 26
Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy
Edgar E. Nollet, Maike Schuldt, Vasco Sequeira, et al.
Circulation Genomic and Precision Medicine (2024) Vol. 17, Iss. 3
Open Access | Times Cited: 3
Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
Maike Schuldt, L. M. Dorsch, Jaco C. Knol, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
M. Jansen, Maike Schuldt, Beau van Driel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4031-4031
Open Access | Times Cited: 7
The diabetic myocardial transcriptome reveals Erbb3 and Hspa2 as a novel biomarkers of incident heart failure
Marcella Conning-Rowland, Marilena Giannoudi, Michael Drozd, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 15, pp. 1898-1906
Open Access | Times Cited: 2
De Novo Missense Mutations in TNNC1 and TNNI3 Causing Severe Infantile Cardiomyopathy Affect Myofilament Structure and Function and Are Modulated by Troponin Targeting Agents
Roua Hassoun, Heidi Budde, Hans Georg Mannherz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9625-9625
Open Access | Times Cited: 16
Targeting Microtubules for the Treatment of Heart Disease
Emily F. Warner, Li Yang, Xuan Li
Circulation Research (2022) Vol. 130, Iss. 11, pp. 1723-1741
Open Access | Times Cited: 9
Mechanisms of the Mitochondrial Unfolded Protein Response in Caenorhabditis elegans and Mammals and Its Roles in Striated Muscles
Tongxiao Luan, Hu Song, W Nie, et al.
Aging and Disease (2024)
Open Access | Times Cited: 1
The Role of Proteostasis Derailment in Cardiac Diseases
Bianca J.J.M. Brundel
Cells (2020) Vol. 9, Iss. 10, pp. 2317-2317
Open Access | Times Cited: 9
Heat Shock Proteins: Potential Modulators and Candidate Biomarkers of Peripartum Cardiomyopathy
Graham Chakafana, Timothy F. Spracklen, Stephen Kamuli, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 8
Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
Maike Schuldt, Beau van Driel, Sıla Algül, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2950-2950
Open Access | Times Cited: 8
The microtubule signature in cardiac disease: etiology, disease stage, and age dependency
Sıla Algül, L. M. Dorsch, Oana Sorop, et al.
Journal of Comparative Physiology B (2023) Vol. 193, Iss. 5, pp. 581-595
Open Access | Times Cited: 3
A Charcot-Marie-Tooth-Causing Mutation in HSPB1 Decreases Cell Adaptation to Repeated Stress by Disrupting Autophagic Clearance of Misfolded Proteins
Xuelian Zhang, Yaru Qiao, Ronglin Han, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2886-2886
Open Access | Times Cited: 4
LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome
Alexandra Viktoria Busley, Óscar Gutiérrez‐Gutiérrez, Elke Hammer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top